Pathophysiology of peripheral arterial disease in diabetes mellitus

J Diabetes. 2017 Feb;9(2):133-140. doi: 10.1111/1753-0407.12474. Epub 2016 Oct 13.

Abstract

Peripheral arterial disease (PAD) increases the risk of lower extremity amputation. It is also an independent predictor of cardiovascular and cerebrovascular ischemic events, affecting both the quality and expectancy of life. Many studies have demonstrated that the prevalence of PAD in patients with diabetes mellitus (DM) is higher than in non-diabetic patients. In diabetic patients, PAD occurs early with rapid progression, and is frequently asymptomatic. Multiple metabolic aberrations in DM, such as advanced glycation end-products, low-density lipoprotein cholesterol, and abnormal oxidative stress, have been shown to worsen PAD. However, the role of DM in PAD is not completely understood. The purpose of the present article is to review and discuss the pathophysiology of PAD in DM.

Keywords: diabetes mellitus; pathophysiology; peripheral arterial disease.

Publication types

  • Review

MeSH terms

  • Cholesterol, LDL / metabolism
  • Diabetes Mellitus / metabolism
  • Diabetes Mellitus / physiopathology*
  • Diabetic Angiopathies / metabolism
  • Diabetic Angiopathies / physiopathology*
  • Glycation End Products, Advanced / metabolism
  • Humans
  • Lower Extremity / blood supply
  • Lower Extremity / physiopathology*
  • Lower Extremity / surgery
  • Peripheral Arterial Disease / metabolism
  • Peripheral Arterial Disease / physiopathology*
  • Reactive Oxygen Species / metabolism
  • Risk Assessment
  • Risk Factors

Substances

  • Cholesterol, LDL
  • Glycation End Products, Advanced
  • Reactive Oxygen Species